← back to search

Kavita Singh

Heidelberg University · DE
Area of research
Endocrinology, Diabetes and Metabolism · Infectious Diseases
Research interest
Research interests include Diabetes Management and Education, Diabetes, Cardiovascular Risks, and Lipoproteins, COVID-19 Clinical Research Studies, and Health Systems, Economic Evaluations, Quality of Life.
h-index
24
citations
1,915
works
131
NIH funding
primary concept
email

Recent publications

Long COVID Syndrome, Mortality and Morbidity in Patients Hospitalized with COVID-19 From 16 Countries: The World Heart Federation Global COVID-19 Study
Global Heart 2025cited by 6position: middledoi
Apolipoprotein B - An ideal biomarker for atherosclerosis?
Indian Heart Journal 2024cited by 22position: firstdoi
Individual-level determinants of breast and cervical cancer screening and early testing in two regionally representative urban Indian populations
Preventive Medicine Reports 2024cited by 2position: middledoi
Greater Disease Severity and Worse Clinical Outcomes in Patients Hospitalised with COVID-19 in Africa
Global Heart 2024cited by 2position: middledoi
Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Global Heart 2022cited by 31position: middledoi
Electrocardiographic findings and prognostic values in patients hospitalised with COVID-19 in the World Heart Federation Global Study
Heart 2022cited by 18position: middledoi
Feasibility Trial of Yoga Programme for Type 2 Diabetes Prevention (YOGA-DP) among High-Risk People in India: A Qualitative Study to Explore Participants’ Trial- and Intervention-Related Barriers and Facilitators
International Journal of Environmental Research and Public Health 2022cited by 11position: middledoi
Correction: Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
Global Heart 2022cited by 2position: middledoi
Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study
BMC Public Health 2021cited by 148position: firstdoi
Patient experiences and perceptions of chronic disease care during the COVID-19 pandemic in India: a qualitative study
BMJ Open 2021cited by 42position: firstdoi
Assessment of Studies of Quality Improvement Strategies to Enhance Outcomes in Patients With Cardiovascular Disease
JAMA Network Open 2021cited by 30position: firstdoi
Celiac disease poses significant risk in developing depression, anxiety, headache, epilepsy, panic disorder, dysthymia: A meta-analysis
Indian Journal of Gastroenterology 2021cited by 24position: middledoi
The World Heart Federation Global Study on COVID-19 and Cardiovascular Disease
Global Heart 2021cited by 20position: middledoi
A Comparison of Lipids and apoB in Asian Indians and Americans
Global Heart 2021cited by 14position: firstdoi
Yoga Program for Type 2 Diabetes Prevention (YOGA-DP) Among High-Risk People: Qualitative Study to Explore Reasons for Non-participation in a Feasibility Randomized Controlled Trial in India
Frontiers in Public Health 2021cited by 12position: middledoi
Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings
Global Heart 2020cited by 21position: middledoi
Development of a Yoga Program for Type-2 Diabetes Prevention (YOGA-DP) Among High-Risk People in India
Frontiers in Public Health 2020cited by 20position: middledoi
Effectiveness of an mHealth-Based Electronic Decision Support System for Integrated Management of Chronic Conditions in Primary Care
Circulation 2019cited by 121position: middledoi
Prevalence of sustained hypertension and obesity among urban and rural adolescents: a school-based, cross-sectional study in North India
BMJ Open 2019cited by 42position: middledoi
Effectiveness and cost-effectiveness of a Yoga-based Cardiac Rehabilitation (Yoga-CaRe) program following acute myocardial infarction: Study rationale and design of a multi-center randomized controlled trial
International Journal of Cardiology 2019cited by 26position: middledoi
Development of a Yoga-Based Cardiac Rehabilitation (Yoga-CaRe) Programme for Secondary Prevention of Myocardial Infarction
Evidence-based Complementary and Alternative Medicine 2019cited by 20position: middledoi
Implementation and acceptability of a heart attack quality improvement intervention in India: a mixed methods analysis of the ACS QUIK trial
Implementation Science 2019cited by 10position: middledoi
Cost-effectiveness of a fixed dose combination (polypill) in secondary prevention of cardiovascular diseases in India: Within-trial cost-effectiveness analysis of the UMPIRE trial
International Journal of Cardiology 2018cited by 27position: firstdoi
Acceptability of a decision‐support electronic health record system and its impact on diabetes care goals in South Asia: a mixed‐methods evaluation of the <scp>CARRS</scp> trial
Diabetic Medicine 2018cited by 23position: firstdoi
A16184 Clinical profile of acute myocardial infarction patients with and without hypertension
Journal of Hypertension 2018cited by 2position: middledoi
Protocol for the mWellcare trial: a multicentre, cluster randomised, 12-month, controlled trial to compare the effectiveness of mWellcare, an mHealth system for an integrated management of patients with hypertension and diabetes, versus enhanced usual care in India
BMJ Open 2017cited by 28position: middledoi
Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals
Annals of Internal Medicine 2016cited by 112position: middledoi
Improving diabetes care: Multi-component cardiovascular disease risk reduction strategies for people with diabetes in South Asia—The CARRS Multi-center Translation Trial
Diabetes Research and Clinical Practice 2012cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Dorairaj Prabhakaran · Hindustan Institute of Technology and Science24 papers (2012–2025)Nikhil Tandon · Indian Institute of Public Health Gandhinagar16 papers (2012–2024)Dimple Kondal · Centre for Chronic Disease Control9 papers (2016–2025)K.M. Venkat Narayan · Emory University8 papers (2012–2024)Vamadevan S. Ajay · XLIM7 papers (2012–2019)Pablo Perel · London School of Hygiene & Tropical Medicine7 papers (2017–2025)Sanjay Kinra · London School of Hygiene & Tropical Medicine6 papers (2018–2022)Mohammed K. Ali · Aswan University6 papers (2012–2024)Ambuj Roy · Department of Health Services5 papers (2017–2020)Kaushik Chattopadhyay · Lifespan5 papers (2019–2022)Raji Devarajan · Public Health Foundation of India5 papers (2016–2019)Karen Sliwa · World Heart Federation5 papers (2020–2025)Viswanathan Mohan · University of Edinburgh4 papers (2012–2024) · 4 papers (2020–2025)Sarah Lewis · Materials Solutions (United Kingdom)3 papers (2020–2022)Amitava Banerjee · University College Hospital3 papers (2020–2025)Roopa Shivashankar · Indian Council of Medical Research3 papers (2012–2018) · 3 papers (2017–2019) · 3 papers (2020–2022)Tess Harris · University of London3 papers (2020–2022)